BIOX
Bioceres Crop Solutions Corp. Ordinary Shares
Agricultural Chemicals
BIOX Stock Analysis: Buy, Sell, or Hold?
$0.21
-0.01 (-5.41%)
▼
5d:
-10.31%
30d:
-28.56%
90d:
-51.96%
QUANTITATIVE VERDICT
HOLD
LOW Confidence (86%)
Quality Score
60/100
Position
OVERSOLD
30-Day Fair Range
$0.21 – $0.30
Position: OVERSOLD
Forward P/E & Valuation
4.2x
CHEAP
vs 10.0x historical avg
Wall Street Target
$2.00
+852.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.21 / $0.26
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: BIOX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Get Alerted When BIOX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: BIOX is currently trading at $0.21, which is considered oversold relative to its 30-day fair value range of $0.21 to $0.30. From a valuation perspective, the stock is trading at a discount (Forward PE: 4.2) compared to its historical average (10.0). Remarkably, the market is currently pricing in an annual earnings decline of 25.0% over the next few years. This pessimistic expectation contrasts with the company's recent 34.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, BIOX is in a downtrend. The price is currently testing key support at $0.21. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.4% recently.
Market Sentiment: BIOX scores 77/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $2.00 (+852.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BIOX is in a downtrend. The price is currently testing key support at $0.21. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.4% recently.
Market Sentiment: BIOX scores 77/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $2.00 (+852.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.21 -
$0.30
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
85.7%
Trading Range & Key Levels
30-Day Trading Range
$0.21 -
$0.30
Current vs Trading Range
OVERSOLD
Support Level
$0.21
Resistance Level
$0.26
Current Trend
Downtrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (77/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.4%)
- BULLISH: Trading 852.4% below Wall St target ($2.00)
- CAUTION: Bottoming setup, but lagging the sector by 14% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-10.3%) - monitor closely
Fundamental Context
Forward P/E (Next Year Est.)
4.20
Wall Street Target
$2.00
(+852.4%)
Revenue Growth (YoY)
-23.4%
Earnings Growth (YoY)
34.4%
Profit Margin
-108.5%
Valuation Discount vs History
-25.0% cheaper
PE vs Historical
4.2 vs 10.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-25.0%
(market-implied from PE analysis)
1-Year Target
$0.19
(-10%)
2-Year Target
$0.17
(-19%)
3-Year Target
$0.15
(-27%)
3-Yr Target (if PE normalizes)
(PE: 4→10)
$0.36
(+74%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 4.2 to 10.0
Stabilization Target:
$0.50
(+138.1%)
PE Expansion Potential:
+138.1%
Share BIOX Analysis
Share this live BIOX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (BIOX)
Neutral
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Apr 26, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages were entirely bullish with no bearish sentiment detected. No recent news articles were available for $BIOX.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 15, 2026 11:23 AM ET
Data refreshes hourly during market hours. Next update: 12:23 PM
Data refreshes hourly during market hours. Next update: 12:23 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BIOX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Agricultural Inputs Stocks
Top-rated stocks in Agricultural Inputs by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTR
Nutrien Ltd |
BUY
26 analysts |
$77 | 51 HOLD |
|
CTVA
Corteva Inc |
STRONG BUY
16 analysts |
$15 | 46 HOLD |
|
CF
CF Industries Holdings I… |
SELL
22 analysts |
$130 | 46 HOLD |
|
MOS
The Mosaic Company |
HOLD
20 analysts |
$25 | 30 SELL |
|
SMG
Scotts Miracle-Gro Compa… |
STRONG BUY
8 analysts |
$76 | 41 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive BIOX Research Pages
